Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KP.3.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KW.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KU.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.4.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.55NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HH.8.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FM.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FK.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.7.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.8.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EU.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EJ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BM.1.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.123.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.9.2.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EW.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBF.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.37NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EW.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CH.1.1.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBF.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBPNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CH.1.1.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.36NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.37NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.28 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.1.272NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.371NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AA.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.353NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.407NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AA.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.47NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.182NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20190.6US
B.1.1.218NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20190.6US
XBB.1.12.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.22 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.128NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.33NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used